Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response

• Main Authors: Marc-Kendy Paul (Author), Manish Choudhary (Author), Amy Heaps (Author), Rinki Deo (Author), Daniela Moisi (Author), Kelley Gordon (Author), John Mellors (Author), Carlee Moser (Author), Paul Klekotka (Author), Alan Landay (Author), Judith Currier (Author), Joseph Eron (Author), Kara Chew (Author), Davey Smith (Author), Scott Sieg (Author), Urvi Parikh (Author), Jonathan Li (Author)
• Format: Book
• Published: Case Western Reserve University, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Anti-SARS-CoV-2 monoclonal antibodies (mAbs) have played a key role as an antiviral against SARS-CoV-2, but there is a potential for resistance to develop. The interplay between host antibody responses and the development of monoclonal antibody (mAb) resistance is a critical area of inve...